P-261 Phase I Study of Multiple Kinase Inhibitor, TT-00420, in Advanced, Refractory Cholangiocarcinoma
Annals of Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined